Members of the Exchange are hereby informed that the under mentioned new securities of Cipla Ltd. (Scrip Code: 500087; ISIN No. INE059A01026) are listed and permitted for trading on the Exchange with effect from Monday October 25, 2004. Securities 8,488*Equity Shares of Rs. 2/- each (fully paid-up) issued to shareholders of erstwhile Oncocare India Pvt. Ltd, Nebumed Pharma Pvt. Ltd., Medule Pharma Pvt. Ltd., Medex Specialities Pvt Ltd., Inhaled Technologies Pvt. Ltd., Lancet Pharma Pvt. Ltd., pursuant to the Scheme of Amalgamation of the Company. Dist. Nos. 29,98,61,746 to 29,98,70,233 * These shares are ranking pari-passu with the old equity shares of the company. 1.The brief particulars of the Scheme of Amalgamation are as mentioned below: a.The Scheme of Amalgamation was sanctioned by the Hon'ble High Court of Bombay vide their orders dated 11th June 2004 and 25th June 2004 respectively. b.The appointed date: 1st April, 2003 c.Date of Allotment: 10th September, 2004 d.Exchange Ratio : 65 shares of Rs. 2/- each for every 1000 shares held in Oncocare India Pvt. Ltd 90 shares of Rs. 2/- for every 1000 shares held in Nebumed Pharma Pvt. Ltd 270 shares of Rs. 2/- for every 1000 shares held in Medule Pharma Pvt. Ltd. 45 shares of Rs. 2/- for every 50 shares of Type A held in Medex Specialities Pvt Ltd. 45 shares of Rs. 2/- for every 50 shares of Type B held in Medex Specialities Pvt Ltd. 120 shares of Rs. 2/- for every 1000 shares held in Inhaled Technologies Pvt. Ltd. 215 shares of Rs. 2/- for every 1000 shares held in Lancet Pharma Pvt. Ltd. 2. Members may please note that 2476 equity shares of the Company bearing the following distinctive nos. are non-transferable for 3 years from date of listing and therefore these shares would not be good delivery in the market till 25-10-2007. The company has confirmed that the share certificates have been enfaced with a stamp regarding its non-transferability. The details of non-transferable shares are given hereinbelow: Number of Client Id/ Distinctive Shares Certificate Nos. Nos. 1238 509361 299867157 - 299868394. 1238 509362 299868395 - 299869632. 3. The company's financial year ends on 31st March.